Armata Pharmaceuticals Inc. is a clinical-stage biotechnology company headquartered in Marina del Rey, California, dedicated to innovating bacteriophage-based therapies aimed at combating antibiotic-resistant infections globally. Leveraging cutting-edge technology and extensive research, the company is at the forefront of addressing critical needs in infectious disease treatment, with a strong emphasis on precision medicine. With a promising pipeline and strategic partnerships, Armata is positioned to make a significant impact in the field of antimicrobial therapies, contributing to a vital solution in the ongoing battle against antibiotic resistance.

NYSE MKT

USA

HEALTHCARE

BIOTECHNOLOGY

5005 MCCONNELL AVENUE, LOS ANGELES, CA, UNITED STATES, 90066

December

$113 Million

-$33.9 Million

0.0

-1.07

$0.00

0.0%

1.134